-transparent.png){kind=logo}
In a single-blind, placebo-controlled crossover study the effects of verapamil (450 +/- 30 mg/day) and propranolol (160 +/- 20 mg/day) on endurance time during submaximal exercise were compared in eight patients with essential hypertension. The drugs were given in randomized order. Each active drug period was preceded by a placebo phase. Endurance tests were performed during both placebo periods and treatment with verapamil and propranolol by bicycle ergometry. Both drugs were equally effective in decreasing resting blood pressure. Verapamil and propranolol reduced exercise heart rate, the effect of propranolol being more pronounced. With placebo, endurance time during exercise was 57 +/- 11 minutes; with propranolol it was 32 +/- 7 minutes (P less than 0.05). Verapamil had no influence on endurance time. The study demonstrates that in contrast to propranolol, verapamil has no influence on exercise tolerance during submaximal work in patients with hypertension.
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
December 1985,
Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
June 1991,
Cardiovascular research,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
May 1985,
International journal of clinical pharmacology, therapy, and toxicology,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
September 1966,
The American journal of cardiology,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
January 1977,
Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
January 1984,
Acta medica Scandinavica. Supplementum,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
August 1986,
Zeitschrift fur Kardiologie,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
August 1987,
International journal of sports medicine,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
October 1982,
The American journal of cardiology,
J Mooy, and
M van Baak, and
R Böhm, and
R Does, and
H Petri, and
J van Kemenade, and
K H Rahn
January 1992,
European journal of clinical pharmacology,
